Medtelligence is dedicated to the creation of innovative, continuing medical education (CME) focusing on cardiovascular and cardiometabolic disease. Through the use of comprehensive, strategically aligned curricula, Medtelligence facilitates the sharing of research, knowledge, and clinical practice skills to engage medical practitioners to fulfill their commitment to lifelong professional development and ultimately improved patient care.
Treating ATTR-CM With a Novel Therapeutic Approach: Understanding the ATTRibutes to Success
Treating ATTR-CM With a Novel Therapeutic Approach: Understanding the ATTRibutes to Success
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Improving Symptoms in Patients with HFrEF Using Novel Device Therapy
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
KALMing the Itch: Improving QoL in Patients with CKD-aP
KALMing the Itch: Improving QoL in Patients with CKD-aP
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
Direct from the Heart Failure Clinic: Novel Device Therapy for Patients with HFrEF
Experts Discuss Longevity and Durability with TAVR
Experts Discuss Longevity and Durability with TAVR
